How is AI revolutionizing oncology data? Find out in this special 'New Frontiers' episode (aired on Bloomberg) that explores the evolution of AI-powered oncology Data Intelligence with LARVOL. ? #LARVOL #BloombergTV #NewFrontiers #Tech #Healthcare #Oncology #CancerResearch #Cancer #CancerData #OncologyData | Bruno Larvol
LARVOL
IT 服务与咨询
San Francisco，California 13,127 位关注者
Leveraging AI to turn clinical trial data and market intelligence into actionable insights to accelerate innovation.
关于我们
AI-powered data and market intelligence solutions - We leverage AI to transform clinical trial data and market intelligence into actionable insights to accelerate pharma innovation, competitive strategy, and patient outcomes. Our solutions include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
- 网站
-
https://www.larvol.com
LARVOL的外部链接
- 所属行业
- IT 服务与咨询
- 规模
- 51-200 人
- 总部
- San Francisco，California
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Financial analyst monitoring、Scientific Conferences、life sciences、medical conferences和healthcare
产品
![点击此处查看OMNI]()
OMNI
Business Intelligence (BI) Software
Stay up-to-date with all aspects of your KOL activity. OMNI makes it easy with complete coverage of both on and offline news delivered in real-time to your inbox and our user-friendly online platform.
地点
-
主要
获取路线
548 Mission St
Suite 44120
US，California，San Francisco，94105
LARVOL员工
动态
-
LARVOL转发了
How accurately can AI models correctly identify the presence of FDA black box warnings? Here are the latest benchmark results. #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #ChatGPT #Grok #Gemini #Qwen #Llama #MistralAI #Claude | Bruno Larvol | LARVOL | Amol Akhade | Daniel J. | OpenAI | Mistral AI
-
How accurately can AI models correctly identify the presence of FDA black box warnings? Here are the latest benchmark results. #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #ChatGPT #Grok #Gemini #Qwen #Llama #MistralAI #Claude | Bruno Larvol | LARVOL | Amol Akhade | Daniel J. | OpenAI | Mistral AI
-
Watch the 24th episode of LARVOL CLIN: Building in Public, where? Bruno Larvol and Daniel J. discuss how accurately can AI models currently identify the presence of FDA black box warnings. Watch Now: https://lnkd.in/gCpvVZMm #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #LARVOLCLIN
-
-
Dr. Arturo LoAIza-Bonilla & Dr. Mark Gramling discuss AI’s role in clinical trials and patient matching. They cover how Massive Bio uses AI to streamline the trial matching process and enhance patient care. Dr. LoAIza-Bonilla shares insights on using AI for clinical decision-making, data extraction, and predictive analytics, as well as his work in integrating AI algorithms into clinical practices and educational programs. Tune in.. #ONCOLOGY #LARVOL
#AI in Oncology | LARVOL Onco Data Podcast with Dr. Arturo LoAIza-Bonilla
www.dhirubhai.net
-
We are covering LARVOL’s efforts to benchmark AI models in oncology, focusing on drug approval and black box warning accuracy. They talk about the results of recent tests, examining the strengths and weaknesses of models like ChatGPT, Gemini, Grok, and more. Tune in.. #ONCOLOGY #LARVOL
AI BENCHMARKING | LARVOL CLIN - Building in public: Episode 24
www.dhirubhai.net
-
Join us today at 2PM PT for the latest episode of LARVOL Onco Data Podcast where Mark Gramling and Dr. Arturo LoAIza-Bonilla MD discuss Al advancements for clinical trial recruitment. ? #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights
-
-
Topline results from Phase 3 VERITAC-2 clinical trial. The trial met its primary endpoint in the estrogen receptor 1-mutant (ESR1m) population, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to fulvestrant. #LARVOL #VERITAC2 #Oncology #CancerResearch #CancerData #ClinicalTrials #OncologyDevelopments #BreastCancer | LARVOL | Sara Tolaney | Amol Akhade
-
-
March is Myeloma Action Month - an annual global awareness campaign to raise awareness of Multiple Myeloma. LARVOL remains committed to providing valuable oncology insights to drive progress in cancer research. Here are 5 Multiple Myeloma trials with Anticipated FDA Approvals in 2025. #MyelomaMilestone #MyelomaActionMonth #Myeloma #BloodCancer #BloodCancerResearch #LARVOL #Oncology #CancerResearch #CancerData #ClinicalTrials #OncologyInsights Connect with some of the top voices on X in the field of Myeloma: Mike Thompson, MD, PhD, FASCO | Rafa Fonseca | Vincent Rajkumar | Mohamad Mohty | Samer Al Hadidi | Santhosh Ambika | Rahul Banerjee | Al-Ola Abdallah | Amol Akhade
-
-
-
-
-
+1
-
-
LARVOL Onco Data Podcast: Tune in as Mark Gramling sits down with Dr. Martin Schoen to explore how clinical trial data is transforming the future of oncology. Watch Now: https://lnkd.in/gcgs2srt #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #LARVOLCLIN #OncologyInsights
-